Coronavirus (COVID-19) | Medical Study | Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals

Study Name:
Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals

Question:
Is race associated with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) in the United States?

Findings:
In this cohort study of 11 210 individuals with COVID-19 presenting for care at 92 hospitals across 12 states, there was no difference in all-cause, in-hospital mortality between White and Black patients after adjusting for age, sex, insurance status, comorbidity, neighborhood deprivation, and site of care.

Meaning:
In this study, race was not independently associated with in-hospital mortality after adjusting for differences in sociodemographic and clinical factors.

Source:
JAMA Network | Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) At 92 US Hospitals. 

Related Post

OMICRON BA.4 BA.5

CDC Recommends the First Updated COVID-19 Booster Targeting Omicron BA.4 and BA.5

CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.
Urgent Family Care blog fallback

COVID-19 | Medical Editorial | Convalescent plasma is ineffective for covid-19

Convalescent plasma generated great enthusiasm in the earliest days of the coronavirus disease 2019 (covid-19) pandemic because of a plausible mechanism of action, its 100 year history of use in the treatment of other infectious diseases, and rapid availability from voluntary donors.
Urgent Family Care blog fallback

COVID-19 | Medical Research Study | Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Research Abstract Objective: To investigate the effectiveness of using convalescent plasma to treat moderate coronavirus disease 2019 (covid-19) in adults in India.